Leonard Mazur

Leonard L.
Mazur is the founder of Genesis Pharmaceuticals, founded in 1995, serving as Chief Executive Officer from 1995 to 2003.
Mr. Mazur was the founder of Triax Pharmaceuticals LLC, founded in 2004, serving as Chief Operating Officer from 2005 to 2012.
Mr. Mazur is the founder of Citius Pharmaceuticals, Inc., founded in 2007, holding the titles of Chairman, Chief Executive Officer & Secretary since 2022.
Mr. Mazur was the founder of Akrimax Pharmaceuticals LLC, founded in 2008, serving as Vice Chairman.
Mr. Mazur currently holds the positions of Chairman, President & CEO at Citius Oncology, Inc. since 2024, Trustee at Manor College, and Secretary at NoveCite, Inc. since 2014.
Former positions include Chief Executive Officer at Citius Pharmaceuticals LLC, Chairman & Chief Executive Officer at Citius Oncology, Inc. (Old) from 2022 to 2024, Chairman at Leonard-Meron Biosciences, Inc. in 2016, Independent Director at FC Global Realty, Inc. in 2011, Director at Media Exchange Group, Inc. and Senté, Inc., Independent Director at Intellicell Biosciences, Inc. from 2011 to 2013, Independent Director at Canton Strategic Holdings, Inc. from 2021 to 2025, Vice President-Sales & Marketing at Cooper Laboratories, Inc., Vice President-Sales & Marketing at Bausch Health Americas, Inc. from 1984 to 1988, Executive Vice President at Medicis Pharmaceutical Corp.
from 1989 to 1993, and Vice President-Sales & Marketing at Knoll Pharmaceutical Co. from 1971 to 1984.
Education includes undergraduate and MBAistration degrees from Temple University (Pennsylvania).